Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Which '80s Film Actually Holds Up Today? - 2The most effective method to Consummate the Specialty of Handshaking in Business and Group environments
- 3JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
- 4Find the Standards of Viable Refereeing: Settling Debates with Strategy
- 5Picking Childcare Administrations for Your Loved ones
- Noctourism: the new safari travel trend that's changing the wildlife we can photograph in Africa
- Manual for Financial plan Agreeable PC
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- Impact of NIH funding reductions felt in cancer and infectious disease trials
- Individual Preparation Administrations to Raise Your Wellness Process
- Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
- Extraordinary Guinness World Records That Will Astound You
- Volkswagen Just Revealed a Massive Range-Extended SUV for China, and America Isn’t Getting It
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
